InvestorsObserver is giving TherapeuticsMD Inc (TXMD) an Analyst Rating Rank of 5, meaning TXMD is ranked higher by analysts than 5% of stocks. The average price target for TXMD is $1 and analyst’s rate the stock as a Hold.
Wall Street analysts are rating TXMD a Hold today. Find out what this means to you and get the rest of the rankings on TXMD!